Molecular pathology of thymoma and thymic carcinoma

被引:3
作者
Suster, David I. [1 ]
Basu, Malay Kumar [2 ]
Mackinnon, A. Craig [2 ]
机构
[1] Rutgers State Univ, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA
关键词
Thymoma; thymic carcinoma; GTF2I; molecular; genetics; NUT MIDLINE CARCINOMA; EPITHELIAL TUMORS; STAGING SYSTEM; CLINICOPATHOLOGICAL CORRELATION; MUCOEPIDERMOID CARCINOMA; GENETIC ABERRATIONS; MUTATIONAL STATUS; SINGLE-ARM; CLASSIFICATION; MULTICENTER;
D O I
10.20517/2394-4722.2021.210
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thymic epithelial tumors (TETs) comprise a heterogeneous group of epithelial-derived thymic neoplasms with diverse clinical behavior and underlying molecular genetic features. Owing to their rare nature, the molecular classification of TETs has only recently begun to be fully explored. The advent of advanced molecular studies, particularly the ability to sequence the DNA and RNA of tumors in a massively parallel fashion, has led to an increased understanding of the molecular underpinnings of thymic neoplasia. Thymomas, characterized by a heterogeneous group of molecular alterations, tend to have low mutational burdens and various copy number abnormalities including a characteristic loss of chromosomal material in the region of 6q25.2-p25.3, a recurrent, specific point mutation GTF2I p.L424H, and specific expression of certain microRNAs. Thymic carcinomas, in contrast, are generally characterized by increased tumor mutational burdens, multiple copy number alterations, and varied, non-recurrent, somatic mutations. Advances in molecular knowledge of TETs allow for more precise molecular classification of these tumors, and the presence of specific alterations aids in the diagnosis of borderline lesions. In the future, additional molecular studies will better delineate the molecular landscape of these tumors and may one day allow for more targeted treatment algorithms. This review aims to cover the current understanding of the molecular alterations thus far identified in thymomas and thymic carcinomas.
引用
收藏
页数:11
相关论文
共 80 条
[1]   Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma [J].
Alekseyenko, Artyom A. ;
Walsh, Erica M. ;
Zee, Barry M. ;
Pakozdi, Tibor ;
Hsi, Peter ;
Lemieux, Madeleine E. ;
Dal Cin, Paola ;
Ince, Tan A. ;
Kharchenko, Peter V. ;
Kuroda, Mitzi I. ;
French, Christopher A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (21) :E4184-E4192
[2]   Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization [J].
Chen, PCH ;
Pan, CC ;
Yang, AH ;
Wang, LS ;
Chiang, H .
JOURNAL OF PATHOLOGY, 2002, 197 (05) :684-688
[3]   A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression [J].
Christopoulos, Petros ;
Dopfer, Elaine P. ;
Malkovsky, Miroslav ;
Esser, Philipp R. ;
Schaefer, Hans-Eckart ;
Marx, Alexander ;
Kock, Sylvia ;
Rupp, Nicole ;
Lorenz, Myriam R. ;
Schwarz, Klaus ;
Harder, Jan ;
Martin, Stefan F. ;
Werner, Martin ;
Bogdan, Christian ;
Schamel, Wolfgang W. A. ;
Fisch, Paul .
JOURNAL OF IMMUNOLOGY, 2015, 194 (07) :3045-3053
[4]   Thymoma with a t(15;22)(p11;q11) [J].
DalCin, P ;
DeWolfPeeters, C ;
Deneffe, G ;
Fryns, JP ;
VandenBerghe, H .
CANCER GENETICS AND CYTOGENETICS, 1996, 89 (02) :181-183
[5]   Thymic epithelial turnours: A population-based study of the incidence, diagnostic procedures and therapy [J].
de Jong, Wouter K. ;
Blaauwgeers, Johannes L. G. ;
Schaapveld, Michael ;
Timens, Wim ;
Klinkenberg, Theo J. ;
Groen, Harry J. M. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) :123-130
[6]  
Detterbeck FC., 2017, AJCC CANC STAGING MA, P423, DOI [DOI 10.1007/978-3-319-40618-3_35, 10.1007/978-3-319-40618-3_35]
[7]   The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors [J].
Detterbeck, Frank C. ;
Stratton, Kelly ;
Giroux, Dorothy ;
Asamura, Hisao ;
Crowley, John ;
Falkson, Conrad ;
Filosso, Pier Luigi ;
Frazier, Aletta A. ;
Giaccone, Giuseppe ;
Huang, James ;
Kim, Jhingook ;
Kondo, Kazuya ;
Lucchi, Marco ;
Marino, Mirella ;
Marom, Edith M. ;
Nicholson, Andrew G. ;
Okumura, Meinoshin ;
Ruffini, Enrico ;
Van Schil, Paul .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) :S65-S72
[8]   Thymic tumor with adenoid cystic carcinomalike features -: A clinicopothologic study of 4 cases [J].
Di Tommaso, Luca ;
Kuhn, Elisabetta ;
Kurrer, Michael ;
Zettl, Andreas ;
Marx, Alex ;
Mueller-Hermelink, Hans Konrad ;
Roncalli, Massimo ;
Rosai, Juan .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1161-1167
[9]   Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants [J].
Edmonson, Michael N. ;
Patel, Aman N. ;
Hedges, Dale J. ;
Wang, Zhaoming ;
Rampersaud, Evadnie ;
Kesserwan, Chimene A. ;
Zhou, Xin ;
Liu, Yanling ;
Newman, Scott ;
Rusch, Michael C. ;
McLeod, Clay L. ;
Wilkinson, Mark R. ;
Rice, Stephen, V ;
Soussi, Thierry ;
Taylor, J. Paul ;
Benatar, Michael ;
Becksfort, Jared B. ;
Nichols, Kim E. ;
Robison, Leslie L. ;
Downing, James R. ;
Zhang, Jinghui .
GENOME RESEARCH, 2019, 29 (09) :1555-1565
[10]   Thymic sarcomatoid carcinoma with skeletal muscle differentiation: report of two cases, one with cytogenetic analysis [J].
Eimoto, T ;
Kitaoka, M ;
Ogawa, H ;
Niwa, H ;
Murase, T ;
Tateyama, H ;
Inagaki, H ;
Soji, T ;
Wang, HJ .
HISTOPATHOLOGY, 2002, 40 (01) :46-57